Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)

Colon cancer is a type of cancer that occurs in the colon or rectum. Therefore, sometimes it is also known as colorectal cancer (CRC). It is a leading cause of cancer-related deaths worldwide, even though there are available treatments for colon cancer, undesirable side effects often accompany it. E...

Full description

Saved in:
Bibliographic Details
Main Author: Shuang, Wee Lu
Format: Monograph
Language:en
Published: Universiti Sains Malaysia 2025
Subjects:
Online Access:http://eprints.usm.my/63405/1/Wee%20Lu%20Shuang-E.pdf
http://eprints.usm.my/63405/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1854094243137585152
author Shuang, Wee Lu
author_facet Shuang, Wee Lu
author_sort Shuang, Wee Lu
building Hamzah Sendut Library
collection Institutional Repository
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
continent Asia
country Malaysia
description Colon cancer is a type of cancer that occurs in the colon or rectum. Therefore, sometimes it is also known as colorectal cancer (CRC). It is a leading cause of cancer-related deaths worldwide, even though there are available treatments for colon cancer, undesirable side effects often accompany it. Etlingera elatior, known as bunga kantan in Malaysia, is a traditional medicinal plant with high potential therapeutic effects with excellent antimicrobial, antioxidant, anticancer, antidiabetic, anti-inflammation, and anti-ageing properties. However, limited scientific research has been conducted on its antitumour effects against colon cancer. Therefore, this study investigates the in vivo antitumour effects of E. elatior flower aqueous extract (EEAE). EEAE is extracted using the sonication method. Toxicological assessment was performed using the brine shrimp lethality assay (BSLA) with a series of concentrations including concentrations of 10 mg/ml, 1 mg/ml, 3 mg/ml, 300 μg/ml, 100 μg/ml, 30 μg/ml, and 10 μg/ml. The LC50 of EEAE determined after the 24-hour incubation period was 2286 ppm (μg/ml), classifying EEAE as non-toxic based on Meyer and Clarkson toxicity standards. The antitumour efficacy of EEAE was further evaluated in an Azoxymethane-induced colon cancer model using male Sprague-Dawley rats. Histological analysis with Hematoxylin and Eosin (H&E) and Masson-Trichrome (MT) staining demonstrated substantial improvements in colon morphology upon treatment with EEAE. These findings suggest that EEAE is a promising natural product with antitumour properties against colon cancer, with no observed toxicity in vivo. Further research is warranted to explore its therapeutic potential and underlying mechanisms
format Monograph
id my.usm.eprints.63405
institution Universiti Sains Malaysia
language en
publishDate 2025
publisher Universiti Sains Malaysia
record_format eprints
spelling my.usm.eprints.63405 http://eprints.usm.my/63405/ Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study) Shuang, Wee Lu R Medicine RC254-282 Neoplasms. Tumors. Oncology (including Cancer) Colon cancer is a type of cancer that occurs in the colon or rectum. Therefore, sometimes it is also known as colorectal cancer (CRC). It is a leading cause of cancer-related deaths worldwide, even though there are available treatments for colon cancer, undesirable side effects often accompany it. Etlingera elatior, known as bunga kantan in Malaysia, is a traditional medicinal plant with high potential therapeutic effects with excellent antimicrobial, antioxidant, anticancer, antidiabetic, anti-inflammation, and anti-ageing properties. However, limited scientific research has been conducted on its antitumour effects against colon cancer. Therefore, this study investigates the in vivo antitumour effects of E. elatior flower aqueous extract (EEAE). EEAE is extracted using the sonication method. Toxicological assessment was performed using the brine shrimp lethality assay (BSLA) with a series of concentrations including concentrations of 10 mg/ml, 1 mg/ml, 3 mg/ml, 300 μg/ml, 100 μg/ml, 30 μg/ml, and 10 μg/ml. The LC50 of EEAE determined after the 24-hour incubation period was 2286 ppm (μg/ml), classifying EEAE as non-toxic based on Meyer and Clarkson toxicity standards. The antitumour efficacy of EEAE was further evaluated in an Azoxymethane-induced colon cancer model using male Sprague-Dawley rats. Histological analysis with Hematoxylin and Eosin (H&E) and Masson-Trichrome (MT) staining demonstrated substantial improvements in colon morphology upon treatment with EEAE. These findings suggest that EEAE is a promising natural product with antitumour properties against colon cancer, with no observed toxicity in vivo. Further research is warranted to explore its therapeutic potential and underlying mechanisms Universiti Sains Malaysia 2025-01 Monograph NonPeerReviewed application/pdf en http://eprints.usm.my/63405/1/Wee%20Lu%20Shuang-E.pdf Shuang, Wee Lu (2025) Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study). Project Report. Universiti Sains Malaysia. (Submitted)
spellingShingle R Medicine
RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
Shuang, Wee Lu
Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)
title Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)
title_full Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)
title_fullStr Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)
title_full_unstemmed Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)
title_short Evaluation of etlingera elatior flower aqueous extract (EEAE) as treatment of colon cancer in rat model (pilot study)
title_sort evaluation of etlingera elatior flower aqueous extract (eeae) as treatment of colon cancer in rat model (pilot study)
topic R Medicine
RC254-282 Neoplasms. Tumors. Oncology (including Cancer)
url http://eprints.usm.my/63405/1/Wee%20Lu%20Shuang-E.pdf
http://eprints.usm.my/63405/
url_provider http://eprints.usm.my/